SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?


To: TEColeman who wrote (582)12/23/1997 9:00:00 PM
From: JF Quinnelly  Respond to of 1728
 
Message 3034399

Incyte Pharmaceuticals, Inc., (Nasdaq: INCY) announced today that it has signed a definitive agreement to acquire Synteni, Inc., a privately held gene expression microarray company based in Fremont, California...Synteni provides microarray services non-exclusively to the pharmaceutical, biotechnology, and agricultural industries. Incyte plans to use this technology to make pre-fabricated microarrays for commercial applications in human, animal, microbial, and plant genomics.